Abstract
In this issue of Blood, Buchanan and coauthors present the development of a specific antidote for ticagrelor.1 In fact, this is the first specific antidote against any antiplatelet agent.
Cite
CITATION STYLE
APA
Erlinge, D. (2015). The first specific antiplatelet antidote. Blood, 125(22), 3372–3374. https://doi.org/10.1182/blood-2015-04-636274
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.
Already have an account? Sign in
Sign up for free